HOME >> BIOLOGY >> NEWS
New Drug "Cocktails" Prove Effective Against Hepatitis

n a daily dose of the Interferon alfa-2b and ribavirin (Rebetol) combinationfor 24 or 48 weeks, while the other half were given interferon alone.Those patients who received the combination did much better than those who didnot. According to the abstract of the research, the drug combination was "significantly more effective than Interferon alone." In addition, "This combination therapy has an acceptable safety profile."

Another study, presented at the AASLD Annual Meeting by Thierry Poynard, MD, of the Hepato Gastro Groupe Hospitale Pitie Salpetriere in Paris, examined the results of an International European trial of the Interferon alfa-2b and ribavirin combination as a treatment for chronic Hepatitis C. This study, too, found the combination to be effective. "Intron A[interferon]/Rebetol combination therapy was significantly more effective than Introl A monotherapy," according to the study abstract. "This is a huge breakthrough," says Poynard.

A third study, also presented by Poynard,unveiled the results of using the Interferon alfa-2b/ribavirin to treat liver fibrosis in Hepatitis C patients. The last stage of liver fibrosis in such patients is cirrhosis, which can be fatal. The huge study of almost 2,000 patients found that the combination of drugs reduces dramatically the rate of liver fibrosis progression. "This is now the most promising form of therapy," says Poynard. "It appears to be both effective and probably cost effective because of the reduction of cirrhosis incidence."

Possible Role of New TT-Virusin Liver Disease

Some 5% of liver disease is of unknown origin. A paper presented at the AASLD Annual meeting by Philip Adjei, Mayo Clinic, examined the possible role in liver disease played by a newly discovered single-strand DNA virus, TT-virus(TTV). Researchers studied patients who had received liver transplants and who showed no evidence of any of the known causes of liver disease. The patients were monitored bo
'"/>

Contact: Kirk Monroe
kirkmonroe@aol.com
202-789-2892
American Association For The Study of Liver Diseases
9-Nov-1998


Page: 1 2 3

Related biology news :

1. Proven method of bone analysis may clarify human origins
2. Researchers Prove Chemoprevention Can Work
3. Drug Combination May Prove Effective To Prevent Recurrence Of Hepatitis C After Transplantation
4. Penn Researchers Prove "Short-Cut" Function Of Myelin Sheath Channel: BetterUnderstanding Of Myelin Should Lead To Therapies For Neuropathies
5. Reengineered Poliovirus Proves Effective As Vector For Prompting Key Immune Response In A Study With Mice
6. Simplified Therapy To Prevent TB Proven Effective In Developing Countries
7. High Levels of Vitamin C Prove Toxic to HIV
8. Effective acne treatments remain elusive, Hopkins researchers find
9. Study Ensures Effective Ways To Measure Macular Pigment Density
10. Discovery Of 13 Genes Expressed In Brain Tumors May Lead To More Effective Diagnosis Or Prevention
11. New Drug Shown Effective Against Vancomycin-Resistant Bacteria

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/7/2020)... ... February 07, 2020 , ... dicentra , a leading ... nutraceutical and dietary supplement industries, announces 2020 membership with the International Probiotics Association ... research pertaining to probiotics. We are thrilled to join our IPA member colleagues ...
(Date:2/5/2020)... , ... February 05, 2020 , ... ... to bring greater ease, efficiency and insight to sample processing within laboratories. ... and biotech laboratories conducting research in various fields, LabKey Sample Manager has been ...
(Date:1/29/2020)... ... January 29, 2020 , ... INDIGO ... toxicology testing solutions, has announced a record earnings year for 2019. With final ... more than a twenty percent increase in revenue and a thirty percent increase ...
Breaking Biology News(10 mins):
(Date:2/11/2020)... (PRWEB) , ... February 11, ... ... company) is pleased to announce the successful results from a long-term follow-up ... using the Inspan interspinous fixation device (INSPAN LLC). Unlike extension block design, ...
(Date:2/5/2020)... (PRWEB) , ... February 05, 2020 , ... Rare ... observance, sponsored by The National Organization for Rare Disorders (NORD), to raise awareness amongst ... ( rarediseaseday.org ). The Balancing Act’s “Behind The Mystery” rare disease series ...
(Date:1/28/2020)... , ... January 28, 2020 ... ... enterprise software solutions for biopharmaceutical R&D, today announced the release of ... Genedata’s focus on supporting the implementation of Multi-Attribute Methods (MAM) for characterizing ...
(Date:1/24/2020)... ... January 24, 2020 , ... The plastic and reconstructive surgeons at ... Jersey epitomize the notion that plastic surgery is much more than just cosmetic surgery ... , Over the last 20 years NJ Top Docs, Dr. Andrew Elkwood, Dr. Michael ...
Breaking Biology Technology:
Cached News: